Miami Judge Orders Insurer to Cover Cancer Patient's $48K Drug
A Miami-Dade judge has ruled that Oscar Health Insurance must cover a $48,500 cancer drug for a Stage 4 pancreatic cancer patient, Pablo Langesfeld. The decision comes after Oscar Health repeatedly denied coverage, claiming the drug was not medically necessary or federally approved for pancreatic cancer. The drug, Avmapki Fakzynja Co Pack, is FDA approved for ovarian cancer and has received 'orphan drug' designation for pancreatic cancer research. The judge found Oscar Health's policy definitions ambiguous, leading to a ruling in favor of the patient, who now hopes this case will help others facing similar insurance battles. 
